{"id":561333,"date":"2026-08-02T12:30:00","date_gmt":"2026-08-02T10:30:00","guid":{"rendered":"https:\/\/medizinonline.com\/?p=561333"},"modified":"2026-08-02T12:34:33","modified_gmt":"2026-08-02T10:34:33","slug":"mecanismes-moleculaires-et-nouvelles-voies-therapeutiques","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/mecanismes-moleculaires-et-nouvelles-voies-therapeutiques\/","title":{"rendered":"M\u00e9canismes mol\u00e9culaires et nouvelles voies th\u00e9rapeutiques"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Les carcinomes thyro\u00efdiens pr\u00e9sentent une h\u00e9t\u00e9rog\u00e9n\u00e9it\u00e9 biologique remarquable, qui influence de plus en plus les pratiques diagnostiques et th\u00e9rapeutiques modernes. Les marqueurs mol\u00e9culaires et les approches th\u00e9rapeutiques innovantes modifient en profondeur la compr\u00e9hension de la pathogen\u00e8se, du pronostic et de la prise en charge clinique.   <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fmecanismes-moleculaires-et-nouvelles-voies-therapeutiques%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Les carcinomes thyro\u00efdiens pr\u00e9sentent une h\u00e9t\u00e9rog\u00e9n\u00e9it\u00e9 biologique remarquable, qui influence de plus en plus les pratiques diagnostiques et th\u00e9rapeutiques modernes. Les marqueurs mol\u00e9culaires et les approches th\u00e9rapeutiques innovantes modifient en&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fmecanismes-moleculaires-et-nouvelles-voies-therapeutiques%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":561334,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Cancer avanc\u00e9 de la thyro\u00efde  ","footnotes":"","_members_access_role":[],"_members_access_error":""},"category":[11549,11404,11531,11389],"tags":[97894,97932,97933,97867,97870,16287,97865,97866,97868,97878,97882,97919,97931,97900,97888,97886,97916,97897,97879,97901,97924,93287,97896,97899,97876,97918,97898,93286,97911,97930,97904,78127,93288,97923,97910,97890,97926,97905,97922,97929,93289,97891,97872,97871,97885,97873,97920,97874,97875,97908,97921,97934,97883,97880,97909,97909,97884,97914,97869,97881,97915,97903,97925,97907,97907,97877,97906,97906,97892,97917,97887,97902,97912,97928,97889,97913,97927,97895,97893],"powerkit_post_featured":[],"class_list":["post-561333","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-fr","category-endocrinologie-et-diabetologie","category-formation-continue","category-oncologie","tag-algorithme-therapeutique-du-cancer-de-la-thyroide","tag-approches-therapeutiques-personnalisees-en-oncologie-suisse","tag-association-de-traitements-cibles-et-immunotherapeutiques-dans-le-cancer-de-la-thyroide","tag-cancer-avance-de-la-thyroide","tag-cancer-de-la-thyroide-refractaire-a-liode-radioactif","tag-carcinome-de-la-thyroide","tag-carcinome-differencie-de-la-thyroide","tag-carcinome-folliculaire-de-la-thyroide","tag-carcinome-papillaire-de-la-thyroide","tag-carcinome-thyroidien-de-type-ntrk-fusion","tag-carcinome-thyroidien-indifferencie","tag-decisions-therapeutiques-personnalisees-dans-le-cadre-du-cancer-de-la-thyroide","tag-decisions-therapeutiques-personnalisees-fondees-sur-les-mutations-des-genes-braf-et-tert","tag-decouverte-fortuite-dun-carcinome-thyroidien-lors-dun-scanner","tag-diagnostic-en-medecine-nucleaire-du-cancer-de-la-thyroide","tag-diagnostic-moderne-du-cancer-de-la-thyroide","tag-diagnostic-moleculaire-du-cancer-de-la-thyroide","tag-dynamique-de-progression-du-cancer-de-la-thyroide","tag-dysfonctionnement-mitochondrial-et-cancer","tag-echographie-du-cancer-de-la-thyroide","tag-efficacite-du-selpercatinib-et-du-pralsetinib-dans-les-cas-de-fusions-ret","tag-entrectinib","tag-evaluation-de-la-charge-tumorale-dans-le-cancer-de-la-thyroide","tag-evolution-epidemiologique-du-cancer-de-la-thyroide","tag-expression-du-pd-l1-dans-le-cancer-de-la-thyroide","tag-facteurs-de-risque-genetiques-du-cancer-de-la-thyroide","tag-facteurs-pronostiques-du-cancer-de-la-thyroide","tag-fusion-ntrk","tag-immunotherapie-du-cancer-de-la-thyroide","tag-importance-des-facteurs-de-risque-genetiques-dans-la-chirurgie-thyroidienne","tag-inhibiteurs-de-la-ret","tag-inhibiteurs-de-pd-1","tag-inhibiteurs-de-trk","tag-inhibiteurs-de-trk-dans-les-carcinomes-thyroidiens-presentant-des-fusions-ntrk","tag-inhibiteurs-du-pd-l1","tag-inhibiteurs-multikinases-cancer-de-la-thyroide","tag-inhibiteurs-pd-1-pd-l1-dans-le-cancer-avance-de-la-thyroide","tag-inhibiteurs-selectifs-de-la-ret","tag-inhibiteurs-selectifs-de-ret-dans-les-carcinomes-thyroidiens-presentant-une-mutation-du-gene-ret","tag-integration-du-diagnostic-moleculaire-dans-la-planification-du-traitement-chirurgical","tag-larotrectinib","tag-lenvatinib-cancer-de-la-thyroide","tag-marqueurs-genetiques-du-cancer-de-la-thyroide","tag-mecanismes-moleculaires-du-cancer-de-la-thyroide","tag-microenvironnement-immunologique-du-cancer-de-la-thyroide","tag-mutation-braf-v600e","tag-mutation-du-gene-braf","tag-mutation-du-promoteur-du-gene-tert","tag-mutation-ras-et-carcinome-thyroidien","tag-mutation-ret","tag-oncologie-suisse-cancer-de-la-thyroide","tag-optimisation-des-strategies-neoadjuvantes-dans-le-traitement-des-tumeurs-thyroidiennes-localement-avancees","tag-perte-du-symporteur-diodure-de-sodium","tag-phosphorylation-oxydative-tumeur","tag-pralsetinib","tag-progression-tumorale-du-cancer-de-la-thyroide","tag-reduction-de-la-taille-de-la-tumeur-dans-le-cas-dun-cancer-de-la-thyroide","tag-refacteriete-a-liode-radioactif","tag-reprogrammation-metabolique-du-cancer-de-la-thyroide","tag-resecabilite-du-cancer-de-la-thyroide","tag-resultat-fortuit-dune-irm-carcinome-thyroidien","tag-resultats-cliniques-du-larotrectinib-et-de-lentrectinib","tag-ret-fusion","tag-ret-fusion-et-cancer-de-la-thyroide","tag-selpercatinib","tag-sorafenib-et-cancer-de-la-thyroide","tag-strategies-chirurgicales-dans-le-cancer-de-la-thyroide","tag-stratification-des-risques-lies-au-cancer-de-la-thyroide","tag-surdiagnostic-du-cancer-de-la-thyroide","tag-thyroidite-a-mediation-immunitaire","tag-thyroidite-a-mediation-immunitaire-sous-traitement-par-inhibiteurs-de-points-de-controle-immunitaires","tag-traitement-cible-du-cancer-de-la-thyroide","tag-traitement-cible-neoadjuvant","tag-traitement-cible-neoadjuvant-visant-a-ameliorer-la-resecabilite","tag-traitement-personnalise-du-cancer-de-la-thyroide","tag-traitements-innovants-du-cancer-de-la-thyroide","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-08-11 05:31:29","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":561337,"slug":"meccanismi-molecolari-e-nuove-strategie-terapeutiche","post_title":"Meccanismi molecolari e nuove strategie terapeutiche","href":"https:\/\/medizinonline.com\/it\/meccanismi-molecolari-e-nuove-strategie-terapeutiche\/"},"pt_PT":{"locale":"pt_PT","id":561342,"slug":"mecanismos-moleculares-e-novas-vias-terapeuticas","post_title":"Mecanismos moleculares e novas vias terap\u00eauticas","href":"https:\/\/medizinonline.com\/pt-pt\/mecanismos-moleculares-e-novas-vias-terapeuticas\/"},"es_ES":{"locale":"es_ES","id":561345,"slug":"mecanismos-moleculares-y-nuevas-vias-terapeuticas","post_title":"Mecanismos moleculares y nuevas v\u00edas terap\u00e9uticas","href":"https:\/\/medizinonline.com\/es\/mecanismos-moleculares-y-nuevas-vias-terapeuticas\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/561333","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=561333"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/561333\/revisions"}],"predecessor-version":[{"id":561336,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/561333\/revisions\/561336"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/561334"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=561333"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=561333"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=561333"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=561333"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}